A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
Public ClinicalTrials.gov record NCT00924989. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
Study identification
- NCT ID
- NCT00924989
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Astellas Pharma Inc
- Industry
- Enrollment
- 139 participants
Conditions and interventions
Conditions
Interventions
- OSI-906 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2009
- Primary completion
- Jul 10, 2012
- Completion
- Oct 7, 2012
- Last update posted
- Nov 19, 2024
2009 – 2012
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| TGen Clinical Research Service at Scottsdale Healthcare | Scottsdale | Arizona | 85258 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| UCLA | Los Angeles | California | 90095 | — |
| University of Colorado Denver Cancer Center | Aurora | Colorado | 80045 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| University of Michigan | Ann Arbor | Michigan | 48109-2200 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Dartmouth Medical School | Lebanon | New Hampshire | 03756 | — |
| Duke Clinical Cancer Trials Services | Durham | North Carolina | 27710 | — |
| Ohio State University | Columbus | Ohio | 43202 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232-6307 | — |
| Mary Crowley Cancer Research Center | Dallas | Texas | 75230 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00924989, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00924989 live on ClinicalTrials.gov.